We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are ...
In this article, we are going to take a look at where Akero Therapeutics Inc. (NASDAQ:AKRO) stands against the other stocks. Anyone who’s looked at the market in the last couple of weeks will ...
In a report released today, Jonathan Woo from Phillip Securities maintained a Buy rating on Akero Therapeutics (AKRO – Research Report), with a price target of $80.00. The company’s shares ...
Bank of America Securities analyst Jason Zemansky maintained a Buy rating on Akero Therapeutics (AKRO – Research Report) on February 28 and set a price target of $63.00. The company’s shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results